Year: 2009
Type: article
Abstract: Fragile X syndrome (FXS), a single gene disorder with an expanded CGG allele on the X chromosome, is the most common form of inherited cognitive impairment. The cognitive deficit ranges from mild learning disabilities to severe intellectual disability. The phenotype includes hyperactivity, short attention span, emotional problems including anxiety, social avoidance, poor eye contact, and hyperarousal to sensory stimuli. Imaging studies in FXS have clarified the impact of the FMR1 mutation on brain development and function by documenting structural abnormalities, predominantly in the caudate nucleus and cerebellum, and functional deficits in the caudate, frontal-striatal circuits, and the limbic system. On the basis of current research results, a targeted treatment for FXS will be available in the near future. Currently, a number of psychopharmacological agents are helpful in treating many of the problems in FXS including hyperactivity, attention deficits, anxiety, episodic aggression, and hyperarousal. Although the targeted treatments aim at strengthening synaptic connections, it is essential that these treatments are combined with learning programs that address the cognitive deficits in FXS.
DOI: 10.1002/ddrr.80
Authors: A. Schneider, R.J. Hagerman, D. Hessl
Language: English
Subfield: Genetics
Domain: Life Sciences
Keywords: fragile X syndrome, FMR1 gene, CGG repeat expansion, intellectual disability, learning disabilities, hyperactivity, attention deficits, anxiety, hyperarousal, caudate nucleus, cerebellum, frontostriatal circuits, limbic system, brain development, psychopharmacological treatment, synaptic plasticity, learning programs
Open Access status: bronze
Awards: Development of targeted therapeutic agents for the treatment of FXTAS (2 of 6), Characterization and Treatment of CNS Abnormalities in Premutation Carriers (4 of, G4498805690, Genetics and Physiology of Social Anxiety in Fragile X, Research in Intellectual and Developmental Disabilities, Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers, Genotype-Phenotype Relationships in Fragile X Families
OpenAlex ID: W2013463505
